Cutera Inc. (NASDAQ:CUTR) – Equities research analysts at Griffin Securities dropped their Q4 2016 earnings estimates for Cutera in a report issued on Tuesday. Griffin Securities analyst Z. Ajzenman now anticipates that the brokerage will post earnings of $0.24 per share for the quarter, down from their previous estimate of $0.26. Griffin Securities also issued estimates for Cutera’s Q4 2017 earnings at $0.32 EPS.

Separately, Zacks Investment Research cut shares of Cutera from a “buy” rating to a “hold” rating in a research report on Wednesday.

Earnings History and Estimates for Cutera (NASDAQ:CUTR)

Shares of Cutera (NASDAQ:CUTR) opened at 14.00 on Thursday. Cutera has a 52-week low of $9.83 and a 52-week high of $14.95. The stock’s market capitalization is $183.25 million. The stock has a 50 day moving average of $13.20 and a 200 day moving average of $11.49.

Cutera (NASDAQ:CUTR) last posted its earnings results on Monday, November 7th. The medical device company reported $0.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.04 by $0.08. Cutera had a net margin of 0.38% and a return on equity of 4.82%. The firm earned $30.30 million during the quarter, compared to analysts’ expectations of $28.84 million. During the same period last year, the company posted ($0.07) EPS. The company’s quarterly revenue was up 31.3% compared to the same quarter last year.

A number of large investors have recently made changes to their positions in CUTR. Rhumbline Advisers boosted its stake in shares of Cutera by 7.8% in the second quarter. Rhumbline Advisers now owns 17,006 shares of the medical device company’s stock valued at $191,000 after buying an additional 1,235 shares in the last quarter. TFS Capital LLC boosted its stake in shares of Cutera by 12.9% in the second quarter. TFS Capital LLC now owns 58,763 shares of the medical device company’s stock valued at $659,000 after buying an additional 6,714 shares in the last quarter. Globeflex Capital L P boosted its stake in shares of Cutera by 265.6% in the second quarter. Globeflex Capital L P now owns 11,700 shares of the medical device company’s stock valued at $131,000 after buying an additional 8,500 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Cutera by 11.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 609,527 shares of the medical device company’s stock valued at $6,833,000 after buying an additional 61,028 shares in the last quarter. Finally, BlackRock Investment Management LLC boosted its stake in shares of Cutera by 1.3% in the second quarter. BlackRock Investment Management LLC now owns 52,138 shares of the medical device company’s stock valued at $584,000 after buying an additional 680 shares in the last quarter. Institutional investors own 79.51% of the company’s stock.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

5 Day Chart for NASDAQ:CUTR

Receive News & Stock Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related stocks with our FREE daily email newsletter.